Skip to main content
. 2020 Jun;373(3):488–501. doi: 10.1124/jpet.120.264994

TABLE 1.

Physicochemical and pharmacokinetic parameters of methamphetamine and amphetamine used in the full-body parent-metabolite PBPK model with the integrated mechanistic kidney model and peripheral arm vein sampling site

Parameter Methamphetamine Amphetamine
Physicochemical
 Molecular weight (g/mol) 149.23a 135.21a
 Compound type Basea Basea
 pKa 10.21a 10.01a
 LogP 2.23a 1.85a
 fu,p 0.77b 0.82b
 B/P 1.04b 1.04b
 MDCK cellular permeability (10−6 cm/s) 29.1b 26.9b
Absorption
 ka (h−1) 5c 5c
 Fa 1c 1c
 Fg 1c 1c
Distribution
 Kp,adipose 3d 2d
 Kp,bone 3d 2d
 Kp,brain 9.67e 9.67e
 Kp,gastrointestinal tract 25.2e 25.2e
 Kp,heart 5.21e 5.21e
 Kp,kidney 14.5e 14.5e
 Kp,liver 25e 25e
 Kp,lung 6.94e 6.94e
 Kp,muscle 3d 2d
 Kp,pancreas 12.7e 12.7e
 Kp,skin 3d 2d
 Kp,spleen 11e 11e
Metabolism (l/h)
 CLtotal 18.0f (i.v.) 15.8g (p.o.)
 CLh 9.91h 7.41h
 CLintrinsic 14.4h 9.87h
 CLf 3.29i
Excretion (l/h)
 CLr 8.09f 7.14j
 CLsecretion 48k (16 × 3) 30k (10 × 3)

B/P, blood-to-plasma ratio; CLf, formation clearance; CLh, hepatic clearance; CLintrinsic, metabolic intrinsic clearance; CLr, renal clearance; CLsecretion, renal active secretion clearance at proximal tubule (clearance value of each proximal subsegment S1, S2, and S3); CLtotal, total body clearance (intravenous administration for methamphetamine; oral administration for amphetamine); Fa, fraction absorbed; Fg, fraction passed the enterocyte; ka, absorption rate constant from gut lumen to blood.

a

Collected from www.drugbank.ca.

b

Measured from experiments.

c

Assumed as described in Materials and Methods.

d

Optimized as described in Materials and Methods.

h

Derived as described in Materials and Methods.

k

Optimized as described in Materials and Methods.